Canada · Health Canada Drug Product Database
CIMICIFUGA PLEX
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 53033
- DIN
- 02235035
- Form
- Drops, Granules, Syrup, Pellet, Tablet, Liquid
- Company as listed by source
- SEROYAL INTERNATIONAL INC.
- Source status
- Cancelled Post Market (2009-07-06)
- Source last updated
- 2025-03-22
Source-listed ingredients
- CAULOPHYLLUM THALICTROIDES — 6 X
- CIMICIFUGA RACEMOSA — 6 X
- COPPER — 6 X
- ESTRONE — 12 X
- COTTON PLANT — 6 X
- HISTAMINE DIHYDROCHLORIDE — 12 X
- MAGNESIUM PHOSPHATE DIBASIC — 6 X
- PLATINUM — 8 X
- SEPIA OFFICINALIS L — 6 X
- THYROID — 10 X
- PITUITARY WHOLE — 10 X
- HYPOTHALAMUS — 10 X
These values do not establish equivalence or a dose recommendation.
Packages
- [1-500 Ml Bottle]/ [1-100 L Bottle]/For Granules And Pellets (115-250) [115 Ea
Source and coverage
Open Health Canada Drug Product Database →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse Canada records →